Join
Live feed
·
INSIDERFilingvia Quantisnow
ARS Pharmaceuticals Inc. logo

Chief Business Officer Chakma Justin sold $1,411,742 worth of shares (100,000 units at $14.12), decreasing direct ownership by 42% to 136,380 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SPRY· ARS Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SPRY (ARS Pharmaceuticals Inc.) and more on Quantisnow.